CCND3 is indispensable for the maintenance of B-cell acute lymphoblastic leukemia
Abstract The D-type cyclins (CCND1, CCND2, and CCND3) in association with CDK4/6 are known drivers of cell cycle progression. We reported previously that inactivation of FOXO1 confers growth arrest and apoptosis in B-ALL, partially mediated by subsequent depletion of CCND3. Given that previously the...
Main Authors: | Franz Ketzer, Hend Abdelrasoul, Mona Vogel, Ralf Marienfeld, Markus Müschen, Hassan Jumaa, Thomas Wirth, Alexey Ushmorov |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-01-01
|
Series: | Oncogenesis |
Online Access: | https://doi.org/10.1038/s41389-021-00377-0 |
Similar Items
-
Dependency of B-Cell Acute Lymphoblastic Leukemia and Multiple Myeloma Cell Lines on MEN1 Extends beyond MEN1–KMT2A Interaction
by: Tatjana Magdalena Wolffhardt, et al.
Published: (2023-11-01) -
Association between the polymorphism rs3217927 of CCND2 and the risk of childhood acute lymphoblastic leukemia in a Chinese population.
by: Heng Zhang, et al.
Published: (2014-01-01) -
Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia
by: Hend Abdelrasoul, et al.
Published: (2020-06-01) -
BRD4 PROTAC degrader MZ1 exhibits anti-B-cell acute lymphoblastic leukemia effects via targeting CCND3
by: Li Ma, et al.
Published: (2023-12-01) -
Pharmacokinetic–pharmacodynamic modeling of maintenance therapy for childhood acute lymphoblastic leukemia
by: Anna Gebhard, et al.
Published: (2023-07-01)